BioVentrix Announces Study Design for REVIVE-HF: Randomized Controlled Trial (RCT) in Europe
Advertisement
To demonstrate that treatment with the Revivent TC™ System is more effective than Guideline Directed Medical Therapy (GDMT) for the treatment of ischemic heart failure